The efficacy of commercial smartwatches with a blood pressure‐monitoring feature: A pilot randomized controlled trial

Purpose The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure‐monitoring feature. Design A randomized controlled trial. Methods Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nursing scholarship 2022-05, Vol.54 (3), p.324-331
Main Authors: Yen, Hsin‐Yen, Huang, Wen‐Hsin
Format: Article
Language:English
Subjects:
awareness
Blood Pressure
Chronic illnesses
Clinical trials
Disease prevention
Efficacy
Health behavior
Health care
Health promotion
Health Status
Heart rate
Humans
Hypertension
Intervention
Obesity
Outdoor air quality
Physical activity
Pilot Projects
Prevention programs
Resting
Selfmanagement
Selfmonitoring
self‐management
Smartphones
Smartwatches
Social networks
Software
Time use
Wearable computers
Wearable Electronic Devices
wearable technology
Weight control
Young Adult
Young adults
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure‐monitoring feature. Design A randomized controlled trial. Methods Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without a blood pressure‐monitoring feature for 12 weeks. Data were collected using Omron HEM‐907, Inbody 270S, and the International Physical Activity Questionnaire. Findings Results revealed a significant effect and group‐by‐time interaction on diastolic blood pressure. After 12 weeks in participants who wore a smartwatch with a blood pressure‐monitoring feature, the systolic and diastolic blood pressure and resting heart rate had decreased. Conclusion Using commercial smartwatches with a blood pressure‐monitoring feature is a feasible approach to support self‐management, increase awareness, and promote physical activity for health promotion, obesity and chronic disease prevention. Clinical relevance Wearable technologies may be an innovative strategy for preventing high blood pressure by continuous self‐monitoring and healthy behavior modifications.
ISSN:1527-6546
1547-5069
DOI:10.1111/jnu.12740